Evidence map›Paper›PMID 34078456›Full record

ArticleInfectious diseases of poverty2021

Correction to: Risk factors for developing severe COVID-19 in China: an analysis of disease surveillance data.

Meng-Jie Geng, Li-Ping Wang, Xiang Ren, Jian-Xing Yu, Zhao-Rui Chang, Can-Jun Zheng, Zhi-Jie An, Yu Li, Xiao-Kun Yang, Hong-Ting Zhao and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious diseases of poverty, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Meng-Jie GengDivision of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
Li-Ping WangDivision of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
Xiang RenDivision of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
Jian-Xing YuNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhao-Rui ChangDivision of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
Can-Jun ZhengDivision of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhi-Jie AnNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Yu LiDivision of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
Xiao-Kun YangDivision of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
Hong-Ting ZhaoDivision of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhong-Jie LiDivision of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China. lizj@chinacdc.cn.
Guang-Xue HeNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. hegx@chinacdc.cn.
Zi-Jian FengDivision of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China. fengzj@chinacdc.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34078456
PMCPMC8170455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.